Alligator Bioscience AB TEMP

Alligator Bioscience AB TEMP's next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Alligator Bioscience AB TEMP has 280.90M shares outstanding.

As of June 30, 2026, Alligator Bioscience AB TEMP maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 6, 2026, Alligator Bioscience AB TEMP's stock has declined approximately 79.43% over the past 52 weeks.

As of June 30, 2026, Alligator Bioscience AB TEMP holds 16.61M in cash and equivalents against 29.93M in total debt, resulting in a net debt position of -16.61M. Total book value stands at 3.33M, with working capital of -16.96M providing operational flexibility.